Display options
Cite
Bali P, Coker J, Lozano-Pope I, et al. Microbiome Signatures in a Fast- and Slow-Progressing Gastric Cancer Murine Model and Their Contribution to Gastric Carcinogenesis. Microorganisms. 2021;9(1)doi: 10.3390/microorganisms9010189.
Bali, P., Coker, J., Lozano-Pope, I., Zengler, K., & Obonyo, M. (2021). Microbiome Signatures in a Fast- and Slow-Progressing Gastric Cancer Murine Model and Their Contribution to Gastric Carcinogenesis. Microorganisms, 9(1), . https://doi.org/10.3390/microorganisms9010189
Bali, Prerna, et al. "Microbiome Signatures in a Fast- and Slow-Progressing Gastric Cancer Murine Model and Their Contribution to Gastric Carcinogenesis." Microorganisms vol. 9,1 (2021). doi: https://doi.org/10.3390/microorganisms9010189
Bali P, Coker J, Lozano-Pope I, Zengler K, Obonyo M. Microbiome Signatures in a Fast- and Slow-Progressing Gastric Cancer Murine Model and Their Contribution to Gastric Carcinogenesis. Microorganisms. 2021 Jan 17;9(1). doi: 10.3390/microorganisms9010189. PMID: 33477306; PMCID: PMC7829848.
Copy Download .nbib Format: NLM
Share it on

Microorganisms. 2021 Jan 17;9(1). doi: 10.3390/microorganisms9010189.

Microbiome Signatures in a Fast- and Slow-Progressing Gastric Cancer Murine Model and Their Contribution to Gastric Carcinogenesis.

Microorganisms

Prerna Bali, Joanna Coker, Ivonne Lozano-Pope, Karsten Zengler, Marygorret Obonyo

Affiliations

  1. Department of Medicine, School of Medicine, University of California, San Diego, La Jolla, CA 92093, USA.
  2. Department of Pediatrics, University of California, San Diego, La Jolla, CA 92093, USA.
  3. Center for Microbiome Innovation, University of California, San Diego, La Jolla, CA 92093, USA.
  4. Department of Bioengineering, University of California, San Diego, La Jolla, CA 92093, USA.

PMID: 33477306 PMCID: PMC7829848 DOI: 10.3390/microorganisms9010189

Abstract

Gastric cancer is the third most common cause of death from cancer in the world and infection with

Keywords: Helicobacter; Lactobacillales; MyD88; TRIF; gastric cancer; microbiome

References

  1. Sci Rep. 2019 May 7;9(1):7030 - PubMed
  2. Nat Commun. 2019 Jun 20;10(1):2719 - PubMed
  3. Helicobacter. 2011 Oct;16(5):398-404 - PubMed
  4. Scand J Gastroenterol Suppl. 1995;212:13-8 - PubMed
  5. J Clin Invest. 2008 Dec;118(12):3930-42 - PubMed
  6. Methods Mol Biol. 2012;921:89-98 - PubMed
  7. Lancet. 1975 Jul 12;2(7924):58-60 - PubMed
  8. Microb Ecol. 2013 Apr;65(3):763-72 - PubMed
  9. NAR Genom Bioinform. 2020 Jun;2(2):lqaa023 - PubMed
  10. IARC Monogr Eval Carcinog Risks Hum. 1994;61:1-241 - PubMed
  11. Sci Rep. 2017 Nov 21;7(1):15957 - PubMed
  12. mSystems. 2017 Mar 7;2(2): - PubMed
  13. J Clin Invest. 2013 Sep;123(9):3685-92 - PubMed
  14. Nature. 2012 Jun 13;486(7402):207-14 - PubMed
  15. Vasc Med. 2020 Jun;25(3):210-217 - PubMed
  16. mSystems. 2018 Apr 17;3(3): - PubMed
  17. PLoS One. 2013 Apr 22;8(4):e61217 - PubMed
  18. Gastroenterol Res Pract. 2017;2017:8320496 - PubMed
  19. Science. 2012 Jun 8;336(6086):1262-7 - PubMed
  20. Infect Immun. 2014 Jan;82(1):356-63 - PubMed
  21. mSystems. 2019 Feb 12;4(1): - PubMed
  22. Front Microbiol. 2017 Nov 15;8:2224 - PubMed
  23. PLoS One. 2012;7(3):e33418 - PubMed
  24. J Coll Physicians Surg Pak. 2010 Nov;20(11):773-5 - PubMed
  25. J Med Microbiol. 2009 Apr;58(Pt 4):509-516 - PubMed
  26. Helicobacter. 2014 Dec;19(6):407-16 - PubMed
  27. Gastroenterology. 2005 Jun;128(7):1937-52 - PubMed
  28. Clujul Med. 2017;90(4):369-376 - PubMed
  29. PLoS Pathog. 2017 Oct 5;13(10):e1006573 - PubMed
  30. Nature. 2012 Sep 13;489(7415):220-30 - PubMed
  31. Gastroenterology. 2011 Jan;140(1):210-20 - PubMed
  32. Cancer Res. 2005 Dec 1;65(23):10709-15 - PubMed
  33. PLoS One. 2013 Sep 12;8(9):e75154 - PubMed
  34. Nat Biotechnol. 2019 Aug;37(8):852-857 - PubMed
  35. Sci Rep. 2018 Jan 9;8(1):158 - PubMed

Publication Types

Grant support